Sepsis Syndrome Clinical Trial
Official title:
Diagnostic Accuracy of Clinical and Paraclinical Tools in Sepsis
NCT number | NCT03956043 |
Other study ID # | Sepsis-OUH |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | May 15, 2017 |
Est. completion date | May 15, 2026 |
The sepsis syndrome has recently been more stringently defined as "a life-threatening organ dysfunction caused by a dysregulated host response to infection". Clinical and paraclinical tools are investigated for their ability to adequately recognize sepsis early.
Status | Recruiting |
Enrollment | 1000 |
Est. completion date | May 15, 2026 |
Est. primary completion date | September 15, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients >18 years old with suspected sepsis in the Emergency Department of Oslo University Hospital Oslo Exclusion Criteria: - Non |
Country | Name | City | State |
---|---|---|---|
Norway | Oslo University Hospital | Oslo |
Lead Sponsor | Collaborator |
---|---|
Oslo University Hospital |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Diagnostic accuracy in sepsis | Sensitivity, specificity, predictive values, AUC of clinical criteria of sepsis in the Emergency department, compared to post hoc assesment | within 90 days after inclusion | |
Primary | Prognostic accuracy in sepsis | Sensitivity, specificity, predictive values, AUC of clinical criteria of sepsis in the Emergency department, compared to in hospital, 30 and 90 days mortality | 90 days after inclusion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04560842 -
The Efficacy of High-flow Nasal Cannula Oxygen Therapy in Sepsis Patients
|
N/A | |
Completed |
NCT04475081 -
Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis
|
Phase 3 | |
Completed |
NCT03314831 -
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
|
||
Completed |
NCT03371680 -
Kinetics of Surfactant Proteins, Phosphatidylcholine and Body Water in Intensive Care Unit (ICU)
|
N/A | |
Completed |
NCT00046072 -
A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
|
Phase 2 | |
Enrolling by invitation |
NCT05602584 -
Effect of Immunophenotype on Prognosis of Sepsis
|
||
Completed |
NCT06338111 -
Can we Improve Mortality Prediction in Patients With Sepsis in the Emergency Department
|
||
Completed |
NCT04292431 -
Leukocyte MOrphology and CORticosteroids Response in SEPtic Patients (MOCORSEP)
|
||
Recruiting |
NCT03472170 -
Clinical Trial for Valuation of the Effectiveness of Lactoferrine in the Prevention of Sepsis in New Premature Born. Bimonitorization of the Antinflammatory Mechanisms, Antioxidants and the Intestinal Microbiote.
|
N/A | |
Not yet recruiting |
NCT05382078 -
Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
|
||
Recruiting |
NCT05977153 -
CT for Personalized Mechanical Ventilation
|
N/A | |
Completed |
NCT00448968 -
The Utility of Ischemia Modified Albumin (IMA) in Sepsis
|
N/A | |
Completed |
NCT05246969 -
Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage
|
||
Not yet recruiting |
NCT06446947 -
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
|
||
Recruiting |
NCT05261607 -
Analysis of the Evolution of Mortality in an Intensive Care Unit
|
||
Recruiting |
NCT04203979 -
Sepsis: From Syndrome to Personalized Care
|
||
Recruiting |
NCT03990467 -
Observed Pharmacokinetic of Piperacillin/Tazobactam Compared to Amikacin in ICU
|
N/A | |
Recruiting |
NCT05338359 -
Metrology to Enable Rapid and Accurate Clinical Measurements in Acute Management of Sepsis
|
||
Completed |
NCT02562261 -
Platelet REactivity in Sepsis Syndrome (PRESS)
|
||
Active, not recruiting |
NCT02643121 -
Utility of Presepsin in Children Sepsis
|
N/A |